*	OR T1 T2
R1	Has_value Arg1:T4 Arg2:T5	
R2	Subsumes Arg1:T3 Arg2:T4	
R3	AND Arg1:T6 Arg2:T7	
R4	Has_value Arg1:T8 Arg2:T9	
R5	Has_multiplier Arg1:T11 Arg2:T10	
R6	Has_value Arg1:T12 Arg2:T13	
R7	Subsumes Arg1:T14 Arg2:T15	
R8	Has_value Arg1:T14 Arg2:T16	
R9	Has_value Arg1:T17 Arg2:T18	
T1	Person 0 4	Male
T2	Person 9 15	female
T3	Person 16 26	adolescent
T4	Person 37 41	aged
T5	Value 42 56	13 to 17 years
T6	Condition 73 76	RLS
T7	Measurement 90 115	IRLSSG consensus criteria
T8	Measurement 147 171	Total RLS severity score
T9	Value 175 188	15 or greater
T10	Multiplier 295 338	at least 4 of 7 consecutive evenings/nights
T11	Condition 278 290	RLS symptoms
T12	Measurement 369 380	Body weight
T13	Value 381 401	greater than 33.4 kg
T14	Measurement 439 454	body mass index
T15	Measurement 456 459	BMI
T16	Value 467 486	5th-85th percentile
T17	Measurement 577 607	Estimated creatinine clearance
T18	Value 611 629	at least 60 mL/min
T19	Informed_consent 687 849	Signed patient and parent Institutional Review Board (IRB)-approved informed consent/assent form (as applicable) before any study-related procedures are performed
